# Interactive Brokers Group, Inc.: financial statements, quarterly

IBKR · Nasdaq · CIK 1381197 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ibkr.md) · [Financials](/companies/ibkr/financials.md) · [Filings](/companies/ibkr/filings.md) · [Insiders](/companies/ibkr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ibkr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [385](/filings/0001381197-24-000143.md) | [403 d](/filings/0001381197-26-000062.md) | [438](/filings/0001381197-25-000052.md) | [474](/filings/0001381197-25-000103.md) | [507](/filings/0001381197-25-000158.md) | [558 d](/filings/0001381197-26-000062.md) | [592](/filings/0001381197-26-000093.md) | [578](/filings/0001381197-26-000147.md) | [603](/filings/0001381197-25-000158.md) | [667 d](/filings/0001381197-26-000062.md) | [699](/filings/0001381197-26-000093.md) | [760](/filings/0001381197-26-000147.md) |
| Selling, general and administrative | $m | not reported | not reported | [50.0](/filings/0001381197-25-000052.md) | [52.0](/filings/0001381197-25-000103.md) | [153](/filings/0001381197-25-000158.md) | [59.0 d](/filings/0001381197-26-000062.md) | [62.0](/filings/0001381197-26-000093.md) | [61.0](/filings/0001381197-26-000147.md) | [62.0](/filings/0001381197-25-000158.md) | [62.0 d](/filings/0001381197-26-000062.md) | [68.0](/filings/0001381197-26-000093.md) | [68.0](/filings/0001381197-26-000147.md) |
| Interest expense | $m | [910](/filings/0001381197-23-000149.md) | [965 d](/filings/0001381197-24-000083.md) | [1,013](/filings/0001381197-24-000097.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [68.0](/filings/0001381197-24-000143.md) | [77.0 d](/filings/0001381197-26-000062.md) | [71.0](/filings/0001381197-25-000052.md) | [71.0](/filings/0001381197-25-000103.md) | [75.0](/filings/0001381197-25-000158.md) | [71.0 d](/filings/0001381197-26-000062.md) | [91.0](/filings/0001381197-26-000093.md) | [98.0](/filings/0001381197-26-000147.md) | [126](/filings/0001381197-25-000158.md) | [99.0 d](/filings/0001381197-26-000062.md) | [117](/filings/0001381197-26-000093.md) | [118](/filings/0001381197-26-000147.md) |
| Net income | $m | [772](/filings/0001381197-24-000143.md) | [739 d](/filings/0001381197-26-000062.md) | [795](/filings/0001381197-25-000052.md) | [809](/filings/0001381197-25-000103.md) | [834](/filings/0001381197-25-000158.md) | [969 d](/filings/0001381197-26-000062.md) | [964](/filings/0001381197-26-000093.md) | [1,006](/filings/0001381197-26-000147.md) | [1,186](/filings/0001381197-25-000158.md) | [1,201 d](/filings/0001381197-26-000062.md) | [1,171](/filings/0001381197-26-000093.md) | [1,338](/filings/0001381197-26-000147.md) |
| Diluted EPS | $ per share | [1.56](/filings/0001381197-24-000143.md) | not reported | [1.61](/filings/0001381197-25-000052.md) | [0.41](/filings/0001381197-25-000103.md) | [0.42](/filings/0001381197-25-000158.md) | not reported | [0.48](/filings/0001381197-26-000093.md) | [0.51](/filings/0001381197-26-000147.md) | [0.59](/filings/0001381197-25-000158.md) | not reported | [0.59](/filings/0001381197-26-000093.md) | [0.69](/filings/0001381197-26-000147.md) |
| Basic EPS | $ per share | [1.57](/filings/0001381197-24-000143.md) | not reported | [1.63](/filings/0001381197-25-000052.md) | [0.42](/filings/0001381197-25-000103.md) | [0.42](/filings/0001381197-25-000158.md) | not reported | [0.49](/filings/0001381197-26-000093.md) | [0.51](/filings/0001381197-26-000147.md) | [0.59](/filings/0001381197-25-000158.md) | not reported | [0.60](/filings/0001381197-26-000093.md) | [0.70](/filings/0001381197-26-000147.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.8](/filings/0001381197-24-000143.md) | [3.8](/filings/0001381197-26-000062.md) | [4.1](/filings/0001381197-25-000052.md) | [3.9](/filings/0001381197-25-000103.md) | [3.6](/filings/0001381197-25-000158.md) | [3.6](/filings/0001381197-26-000062.md) | [3.5](/filings/0001381197-26-000093.md) | [4.7](/filings/0001381197-26-000147.md) | [5.1](/filings/0001381197-25-000158.md) | [5.0](/filings/0001381197-26-000147.md) | [5.1](/filings/0001381197-26-000093.md) | [7.7](/filings/0001381197-26-000147.md) |
| Total assets | $bn | [121](/filings/0001381197-23-000149.md) | [128](/filings/0001381197-25-000036.md) | [132](/filings/0001381197-24-000097.md) | [137](/filings/0001381197-24-000124.md) | [149](/filings/0001381197-24-000143.md) | [150](/filings/0001381197-26-000062.md) | [158](/filings/0001381197-25-000052.md) | [181](/filings/0001381197-26-000147.md) | [200](/filings/0001381197-25-000158.md) | [203](/filings/0001381197-26-000147.md) | [219](/filings/0001381197-26-000093.md) | [247](/filings/0001381197-26-000147.md) |
| Total liabilities | $bn | [107](/filings/0001381197-23-000149.md) | [114](/filings/0001381197-25-000036.md) | [118](/filings/0001381197-24-000097.md) | [121](/filings/0001381197-24-000124.md) | [133](/filings/0001381197-24-000143.md) | [134](/filings/0001381197-26-000062.md) | [140](/filings/0001381197-25-000052.md) | [163](/filings/0001381197-25-000103.md) | [181](/filings/0001381197-25-000158.md) | [183](/filings/0001381197-26-000147.md) | [197](/filings/0001381197-26-000093.md) | [225](/filings/0001381197-26-000147.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.4](/filings/0001381197-23-000149.md) | [3.6](/filings/0001381197-25-000036.md) | [3.7](/filings/0001381197-24-000097.md) | [3.9](/filings/0001381197-24-000124.md) | [4.1](/filings/0001381197-24-000143.md) | [4.3](/filings/0001381197-26-000062.md) | [4.5](/filings/0001381197-25-000052.md) | [4.8](/filings/0001381197-25-000103.md) | [5.1](/filings/0001381197-25-000158.md) | [5.4](/filings/0001381197-26-000147.md) | [5.6](/filings/0001381197-26-000093.md) | [5.9](/filings/0001381197-26-000147.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [979 d](/filings/0001381197-24-000143.md) | [2,369 d](/filings/0001381197-26-000062.md) | [1,683](/filings/0001381197-25-000052.md) | [1,621 d](/filings/0001381197-25-000103.md) | [3,582 d](/filings/0001381197-25-000158.md) | [1,838 d](/filings/0001381197-26-000062.md) | [2,584](/filings/0001381197-26-000093.md) | [7,139 d](/filings/0001381197-26-000147.md) | [4,479 d](/filings/0001381197-25-000158.md) | [1,609 d](/filings/0001381197-26-000062.md) | [3,611](/filings/0001381197-26-000093.md) | [6,216 d](/filings/0001381197-26-000147.md) |
| Dividends paid | $m | [10.0 d](/filings/0001381197-24-000143.md) | [11.0 d](/filings/0001381197-26-000062.md) | [11.0](/filings/0001381197-25-000052.md) | [27.0 d](/filings/0001381197-25-000103.md) | [27.0 d](/filings/0001381197-25-000158.md) | [27.0 d](/filings/0001381197-26-000062.md) | [27.0](/filings/0001381197-26-000093.md) | [35.0](/filings/0001381197-25-000103.md) | [36.0 d](/filings/0001381197-25-000158.md) | [36.0 d](/filings/0001381197-26-000062.md) | [36.0](/filings/0001381197-26-000093.md) | [39.0 d](/filings/0001381197-26-000147.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [103](/filings/0001381197-23-000149.md) | [104](/filings/0001381197-24-000097.md) | [104](/filings/0001381197-24-000124.md) | [107](/filings/0001381197-24-000143.md) | [108](/filings/0001381197-25-000052.md) | [435](/filings/0001381197-25-000103.md) | [438](/filings/0001381197-25-000158.md) | [439](/filings/0001381197-26-000093.md) | [441](/filings/0001381197-26-000147.md) | [447](/filings/0001381197-25-000158.md) | [448](/filings/0001381197-26-000093.md) | [450](/filings/0001381197-26-000147.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,231,651 at 2011-05-06, from the cover of the [10-Q filed 2011-05-06](/filings/0001381197-11-000019.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.